Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Vera

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
Haematologica|August 2, 2016
Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphomaVincent Camus, Aspasia Stamatoullas, Sylvain Mareschal, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2014
FDG PET during radiochemotherapy is predictive of outcome at 1 year in non-small-cell lung cancer patients: a prospective multicentre study (RTEP2)Pierre Vera, Sandrine Mezzani-Saillard, Agathe Edet-Sanson, et al.
Blood Cancer Journal|August 3, 2018
Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohortElodie Bohers, Pierre-Julien Viailly, Stéphanie Becker, et al.
Trials|April 29, 2023
ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trialDana Hartl, Yann Godbert, Xavier Carrat, et al.
Trials|July 11, 2023
Correction: ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trialDana Hartl, Yann Godbert, Xavier Carrat, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2013
Interobserver agreement of qualitative analysis and tumor delineation of 18F-fluoromisonidazole and 3'-deoxy-3'-18F-fluorothymidine PET images in lung cancerSébastien Thureau, Philippe Chaumet-Riffaud, Romain Modzelewski, et al.
Frontiers in Oncology|May 29, 2026
Predicting survival of patients treated with antibody-drug conjugates in early-phase clinical trials using AI-quantified 3D body composition on CT scansMatthieu Delaye, Littisha Lawrance, Younes Belkouchi, et al.
Head and Neck Tumor Segmentation and Outcome Prediction : Third Challenge, HECKTOR 2022, Held in Conjunction with MICCAI 2022, Singapore, September 22, 2022, Proceedings. Head and Neck Tumor Segmentation Challenge (3Rd : 2022 : Singapor|May 17, 2023
Overview of the HECKTOR Challenge at MICCAI 2022: Automatic Head and Neck Tumor Segmentation and Outcome Prediction in PET/CTVincent Andrearczyk, Valentin Oreiller, Moamen Abobakr, et al.
The Lancet. Oncology|August 12, 2024
Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [<sup>18</sup>F]FDG-PET tumour residual uptake at 42 Gy (RTEP7-IFCT-1402): a multicentre, randomised, controlled phase 2 trialPierre Vera, Sébastien Thureau, Florence Le Tinier, et al.
The New England Journal of Medicine|March 9, 2022
Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid CancerSophie Leboulleux, Claire Bournaud, Cecile N Chougnet, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Haematologica|August 2, 2016
Detection and prognostic value of recurrent exportin 1 mutations in tumor and cell-free circulating DNA of patients with classical Hodgkin lymphomaVincent Camus, Aspasia Stamatoullas, Sylvain Mareschal, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 25, 2014
FDG PET during radiochemotherapy is predictive of outcome at 1 year in non-small-cell lung cancer patients: a prospective multicentre study (RTEP2)Pierre Vera, Sandrine Mezzani-Saillard, Agathe Edet-Sanson, et al.
Blood Cancer Journal|August 3, 2018
Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohortElodie Bohers, Pierre-Julien Viailly, Stéphanie Becker, et al.
Trials|April 29, 2023
ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trialDana Hartl, Yann Godbert, Xavier Carrat, et al.
Trials|July 11, 2023
Correction: ESTIMation of the ABiLity of prophylactic central compartment neck dissection to modify outcomes in low-risk differentiated thyroid cancer: a prospective randomized trialDana Hartl, Yann Godbert, Xavier Carrat, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 7, 2013
Interobserver agreement of qualitative analysis and tumor delineation of 18F-fluoromisonidazole and 3'-deoxy-3'-18F-fluorothymidine PET images in lung cancerSébastien Thureau, Philippe Chaumet-Riffaud, Romain Modzelewski, et al.
Frontiers in Oncology|May 29, 2026
Predicting survival of patients treated with antibody-drug conjugates in early-phase clinical trials using AI-quantified 3D body composition on CT scansMatthieu Delaye, Littisha Lawrance, Younes Belkouchi, et al.
Head and Neck Tumor Segmentation and Outcome Prediction : Third Challenge, HECKTOR 2022, Held in Conjunction with MICCAI 2022, Singapore, September 22, 2022, Proceedings. Head and Neck Tumor Segmentation Challenge (3Rd : 2022 : Singapor|May 17, 2023
Overview of the HECKTOR Challenge at MICCAI 2022: Automatic Head and Neck Tumor Segmentation and Outcome Prediction in PET/CTVincent Andrearczyk, Valentin Oreiller, Moamen Abobakr, et al.
The Lancet. Oncology|August 12, 2024
Adaptive radiotherapy (up to 74 Gy) or standard radiotherapy (66 Gy) for patients with stage III non-small-cell lung cancer, according to [<sup>18</sup>F]FDG-PET tumour residual uptake at 42 Gy (RTEP7-IFCT-1402): a multicentre, randomised, controlled phase 2 trialPierre Vera, Sébastien Thureau, Florence Le Tinier, et al.
The New England Journal of Medicine|March 9, 2022
Thyroidectomy without Radioiodine in Patients with Low-Risk Thyroid CancerSophie Leboulleux, Claire Bournaud, Cecile N Chougnet, et al.
Pageof 15